GlassScriptPhysician profile
Dale S Barwick
NPI 1114052255
$3,196.31
in general payments reported to CMS, 2019-2025
33 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,417 · 2022: $1,104 · 2023: $428 · 2024: $100 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $713.21 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $373.66 | 2021-2024 | Farxiga, Breztri |
| Novo Nordisk INC | $335.79 | 2021-2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $238.14 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.10 | 2021-2025 | |
| Amgen INC. | $142.93 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $131.21 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.62 | 2021-2022 | |
| Amarin Pharma, INC. | $120.39 | 2021 | |
| Abbott Laboratories | $113.47 | 2021-2023 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $103.47 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.99 | 2021 | |
| Exact Sciences Corporation | $61.83 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $60.55 | 2022-2023 | |
| Esperion Therapeutics, INC. | $53.41 | 2021-2024 | Nexletol |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $50.20 | 2021 | |
| Xeris Pharmaceuticals, INC. | $41.50 | 2022 | |
| Adlon Therapeutics L.P. | $38.13 | 2021 | |
| Optinose US, INC. | $27.84 | 2021 | |
| Vanda Pharmaceuticals INC. | $26.47 | 2021 | |
| Glaxosmithkline, LLC. | $25.45 | 2021 | |
| Stryker Corporation | $24.84 | 2025 | Clottriever Bold Catheter |
| E.R. Squibb & Sons, L.L.C. | $24.07 | 2021 | |
| Lilly USA, LLC | $23.82 | 2021 | |
| Shield Therapeutics INC | $19.28 | 2023 | Accrufer |
| Ultragenyx Pharmaceutical INC. | $19.15 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.76 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.85 | 2021 | |
| Hologic Sales and Service, LLC | $14.90 | 2023 | Thinprep 2000 Processor, Aptima |
| Teva Pharmaceuticals USA, INC. | $13.65 | 2021 | |
| Merck Sharp & Dohme LLC | $13.27 | 2021 | |
| Nestle Healthcare Nutrition INC. | $11.94 | 2021 | |
| Genentech USA, INC. | $7.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Barwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.